D-0288-2024 Class II Terminated
FDA drug recall D-0288-2024 was initiated by OMEZA LLC on January 19, 2024 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated October 17, 2024). Affected quantity: 4390 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- February 14, 2024
- Initiation Date
- January 19, 2024
- Termination Date
- October 17, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4390 vials
Product Description
Omeza Lidocaine Lavage pain relief oil 10*2mL VIALS
Reason for Recall
CGMP Deviations
Distribution Pattern
US Nationwide
Code Information
Lots: 28622 2-1, Exp. 04/24/2024 286222-3, Exp. 1/25/2024 or 04/25/2024